Request Deal Involvement

Double Point Ventures and DCVC Bio co-led a $100m Series C round in Umoja Biopharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

Real Chemistry

pr advisors

Real Chemistry

or

Principals

MULTIPLE MYELOMA INVESTMENT FUND

bidder

MULTIPLE MYELOMA INVESTMENT FUND

UMOJA BIOPHARMA

target

UMOJA BIOPHARMA

MPM CAPITAL

bidder

MPM CAPITAL

SOFTBANK VISION FUND 2

bidder

SOFTBANK VISION FUND 2

ALEXANDRIA VENTURE INVESTMENTS

bidder

ALEXANDRIA VENTURE INVESTMENTS

CAAS CAPITAL MANAGEMENT

bidder

CAAS CAPITAL MANAGEMENT

YOSEMITE

bidder

YOSEMITE

K2 HEALTHVENTURES

bidder

K2 HEALTHVENTURES

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

QIMING VENTURE PARTNERS

bidder

QIMING VENTURE PARTNERS

DCVC BIO

bidder

DCVC BIO

RTW INVESTMENTS

bidder

RTW INVESTMENTS

DOUBLE POINT VENTURES LLC

bidder

DOUBLE POINT VENTURES LLC

UNIVERSITY OF MINNESOTA ENDOWMENT

bidder

UNIVERSITY OF MINNESOTA ENDOWMENT

ARK INVESTMENT MANAGEMENT LLC

bidder

ARK INVESTMENT MANAGEMENT LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite